Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Vemurafenib: the first drug approved for BRAF-mutant cancer

作者:Gideon Bollag, James Tsai, Jiazhong Zhang, Chao Zhang, Prabha N. Ibrahim, K. B. Nolop, Peter Hirth · 发表于:Nature Reviews Drug Discovery · 年份:2012 · DOI:10.1038/nrd3847 · 被引用次数:833 · 研究领域:Melanoma and MAPK Pathways、Computational Drug Discovery Methods、Synthesis and biological activity